Leah Lawrence

Community oncologists help refer appropriate patients to authorized treatment centers.

Presence of a complex karyotype did not affect progression-free or overall survival.

High prevalence of pathogenic/likely pathogenic variants supports wider testing.

Superiority of the regimen was shown in intermediate- and poor-risk groups, as well as in intention-to-treat populations.

Survivors of NHL should be offered genetic counseling.

Further studies needed to look at relevance outside of the transplant-eligible population.

Emerging overall survival data show a benefit of this type of drug across a variety of patient subgroups.

Data could support regulatory, payer decision making.

A new study challenges the recommended use of cotesting for cervical cancer screening.

Cord blood transplant resulted in poorer nonrelapse mortality and leukemia-free survival.